Baltimore, MD, United States of America

James A Garrett

USPTO Granted Patents = 11 

Average Co-Inventor Count = 4.7

ph-index = 7

Forward Citations = 133(Granted Patents)


Company Filing History:


Years Active: 2009-2023

Loading Chart...
11 patents (USPTO):

Title: Innovations in Sepsis Diagnosis by James A. Garrett

Introduction

James A. Garrett is a prominent inventor based in Baltimore, MD, with a significant contribution to the field of medical diagnostics. He holds a total of 11 patents, showcasing his dedication to advancing healthcare technologies. His work primarily focuses on methods for predicting and diagnosing sepsis, a critical condition that requires timely intervention.

Latest Patents

Garrett's latest patents revolve around the diagnosis of sepsis. He has developed methods for predicting the development of sepsis in subjects at risk. These methods involve evaluating features in a biomarker profile of the subject. If these features satisfy a particular value set, the subject is likely to develop sepsis. Additionally, he has created methods for predicting the development of various stages of sepsis. By assessing a plurality of features in a biomarker profile, he can determine the likelihood of a subject having a specific stage of sepsis. His innovative approaches aim to enhance early detection and improve patient outcomes.

Career Highlights

James A. Garrett is associated with Becton Dickinson and Company Limited, where he continues to contribute to advancements in medical technology. His expertise in sepsis diagnosis has positioned him as a key figure in the field. His work not only reflects his innovative spirit but also his commitment to improving healthcare.

Collaborations

Garrett collaborates with notable colleagues, including Richard L. Moore and Song Shi. Their combined efforts in research and development have furthered the understanding and treatment of sepsis.

Conclusion

James A. Garrett's contributions to the diagnosis of sepsis exemplify the impact of innovation in healthcare. His patents and ongoing work at Becton Dickinson and Company Limited highlight the importance of early detection in improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…